What is NCI H460?

The NCI-H460 cell line was derived by A.F. Gazdar and associates in 1982 from the pleural fluid of a patient with large cell cancer of the lung. Gender Male Karyotype. modal numbr = 57; range = 53 to 65. This is a hypotriploid human cell line.

Can EGFR mutation be cured?

Early-stage EGFR-mutant NSCLC can potentially be cured with surgery or radiation therapy, either with or without chemotherapy.

What is EGFR mutation negative?

If the mutation-status test determines that your tumour is EGFR mutation-negative, your Doctor will likely treat your cancer with chemotherapy. Medical studies have shown that patients with EGFR mutation-negative tumours gain more benefit from chemotherapy than with targeted therapies.

What are BEAS 2B cells?

The BEAS-2B cell line was originally established as a human non-tumorigenic lung epithelial cell line derived from a human lung tissue and has been extensively used as an in vitro non-tumorigenic lung epithelial model in a large variety of studies in association with lung carcinogenesis for over 30 years.

What is EGFR NSCLC?

In the case of EGFR-positive non small cell lung cancer (NSCLC), a mutation, or damage, in a gene causes the EGFR to remain stuck in the “on” position. This “drives” abnormal cell growth, which is what cancer is. EGFR is important in many cancers, including lung cancer.

What causes EGFR NSCLC?

How the EGFR mutation works. EGFR’s job is to help cells grow and divide. In the case of EGFR-positive non small cell lung cancer (NSCLC), a mutation, or damage, in a gene causes the EGFR to remain stuck in the “on” position. This “drives” abnormal cell growth, which is what cancer is.

What is EGFR exon 19 deletion?

Epidermal growth factor receptor (EGFR) exon 19 deletion (E19del) is the most common activating mutation in advanced non–small cell lung cancer (NSCLC) and associates with the sensitivity of EGFR tyrosine kinase inhibitors (TKIs) treatment.

Can EGFR mutation change?

In conclusion, the change of EGFR mutation status after chemotherapy was found by many investigators. Influence of chemotherapy on EGFR mutation status may be one of the explanations for this phenomenon. Intratumoral heterogeneity also plays an important role in diversity of tumor EGFR mutation status.